# Amresco, Inc.

- Location (FDA's records): Solon, OH
- FDA decisions: 39 (1981–1991): 39 510(k) clearances
- Product codes: CIT (3), CIG (3), CGX (3), CIC (2), CHJ (2), CKA (2), CEK (2), CGS (2), CIX (2), CFJ (2), CGA (1), JHY (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K905618: GGT Reagent (Feb 26, 1991)
- K904468: Direct Bilirubin Reagent, 7776/7777/7576/7476/7176 (Jan 17, 1991)
- K905684: Alkaline Phosphatase (Dec 28, 1990)
- K905544: Magnesium Reagent (Dec 27, 1990)
- K905284: HDL-Cholesterol Precipitant 7773/7573/7473/7173 (Dec 11, 1990)
- K904004: Amrescocreat Kinase Reagent 7716/17,7516,7416,7116 (Dec 11, 1990)
- K905096: GGT Reagents, 7738, 7739, 7538, 7438 & 7138 (Nov 28, 1990)
- K904381: Diazo Colorimentry Direct Bilirubin (Oct 12, 1990)

Source page: https://510kreport.com/company/amresco